Notice of Preliminary Results

Source: RNS
RNS Number : 1277W
Itaconix PLC
11 March 2026
 

For release: 07:00, 11 March 2026

 

Itaconix plc

("Itaconix" or the "Company")

Notice of Results and Company Presentation

Itaconix (AIM: ITX) (OTCQB: ITXXF), a leading innovator in high-performance plant-based specialty polymers, announces that its Preliminary Results for the year ended 31 December 2025 will be released on 24 March 2026.

Investor Meet Company presentation

A live presentation will be held on 25 March 2026 at 14:00 GMT.  This presentation is open to all interested parties. Anyone can sign up for free to the Investor Meet Company platform and join the live presentation via:

https://www.investormeetcompany.com/itaconix-plc/register-investor

Questions can be submitted pre-event via your Investor Meet Company dashboard up until 24 March 2026, 09:00 GMT, or at any time during the live presentation.

 

- Ends -

 

Itaconix plc

John R. Shaw / Laura Denner

                             +1 603 775-4400

Rosewood

John West / Llewellyn Angus / Lily Pearce

                      +44 (0)20 7653 8702

Canaccord Genuity - Nominated Adviser and Sole Broker

Adam James / Harry Pardoe

                     +44 (0) 20 7523 8000

 

About Itaconix  

 

Itaconix uses its proprietary plant-based polymer technology platform to produce and sell specialty ingredients that improve the safety, performance, and sustainability of consumer products. The Company's current ingredients are enabling and leading new generations of cost-effective, decarbonized consumer products in home and personal care.   

www.itaconix.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORAKKBDDBKBKND